5 Steps to Building Author Rank for your Dermatology Practice
Google is constantly trying to improve search quality for its users. SEO professionals with robust content strategies in place stand to benefit from this the most. To beat spammers, the search engine giant has been focusing on establishing an ecosystem of "content identity;" the aim is to have a verified source for each piece of content that makes it to search queries. Best Practices for Building Authorship Products and services such as Google+ and Google Authorship are among its long…
  • Latest Ideas

  • Choosing the Right Social Platform for your Medical Mobile Marketing
    With the sharp growth of the mobile social ecosystem, it has become important for medical marketers to be highly strategic about their choices of social platforms with regard to mobile marketing. The target readers keep switching between Facebook, Twitter, Instagram, Pinterest and other networks, and the content is digested differently in each network. For instance, a predominantly visual network such as Pinterest gets more engagement from female audience, while Twitter or Facebook are much more diverse in their user base.…
  • Latest Think Like an Entrepreneur Articles

  • July 2014

    Building a compelling Brand for your Dental or Healthcare Practice
  • Latest Videos

  • Inactive but controversial OTC product ingredients
    What you need to know to better inform your patients Parabens. Phthalates. Chemical fragrances. Sodium lauryl sulfate. These are among the behind-the-scenes ingredients in over-the-counter skin and hair care products that have some of the big cosmetic companies changing the way they formulate moisturizers, soaps, shampoos and anti-aging products. But are these inactive ingredients bad or merely perceived to be bad because of misinformation or different “spins” on the truth? And are their substitutes any better? The science behind many…
    Nivolumab: A review of its use in patients with malignant melanoma
    Nivolumab (Opdivo(®)) is a fully human monoclonal antibody against programmed death receptor-1, a negative regulatory checkpoint molecule with a role in immunosuppression. The drug is administered intravenously and is approved for the treatment of unresectable malignant melanoma in Japan. The potential for intravenous nivolumab to be used in the treatment of advanced malignancies such as melanoma was initially demonstrated in phase I dose-ranging trials. Subsequently, in a noncomparative, open-label, phase II trial, almost one-quarter of Japanese patients with previously treated…
  • Latest Clinical Articles